The immunological component of the cellular inflammatory infiltrate in bronchiectasis

J R Silva1, J A Jones, P J Cole

  • 1Department of Thoracic Medicine, National Heart and Lung Institute, Brompton Hospital, London.

Thorax
|August 1, 1989
PubMed

Insights

Bronchiectasis inflammation involves primarily T lymphocytes, with CD8+ cells dominating CD4+ cells. This suggests cell-mediated immunity plays a key role in airway inflammation in bronchiectasis patients.

Area of Science:

  • Immunology
  • Pulmonology
  • Cell Biology

Background:

  • Bronchiectasis is a chronic lung disease characterized by irreversible airway dilation.
  • The underlying inflammatory mechanisms in bronchiectasis are not fully understood.
  • Identifying immune cell involvement is crucial for understanding disease pathogenesis.

Purpose of the Study:

  • To investigate the specific immune cell populations and their activation status in the bronchial mucosa of patients with bronchiectasis.
  • To elucidate the role of cell-mediated immunity in the inflammatory process of bronchiectasis.

Main Methods:

  • Immunohistological analysis of bronchial biopsy specimens.
  • Utilized a panel of monoclonal antibodies to identify lymphocyte and macrophage subsets.
  • Assessed cellular activation markers like HLA-DR.

Main Results:

  • Inflammatory infiltrate in bronchiectasis predominantly comprised mononuclear cells, mainly T lymphocytes.
  • CD8+ T cells significantly outnumbered CD4+ T cells (2:1 to 10:1 ratio).
  • Dendritic cells and macrophages expressing HLA-DR were present in the infiltrate.

Conclusions:

  • Cell-mediated immunological reactions are implicated in the airway inflammation associated with bronchiectasis.
  • The findings support a role for T-cell driven immune responses in bronchiectasis pathogenesis.
  • Further research into immunomodulatory therapies may be beneficial for bronchiectasis treatment.

Related Concept Videos

Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...